Urologix, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ULGX research report →
About the company
Established in 1991 and headquartered in Minneapolis, Minnesota, Urologix, Inc. specializes in the development, production, promotion, and distribution of minimally invasive medical devices across the United States. The company's innovative solutions target the treatment of obstructions and related symptoms caused by benign prostatic hyperplasia (BPH).
- CEO
- Bryon Merade
- IPO
- 1996
- Employees
- 61
- HQ
- Minneapolis, MN, US
Price Chart
- Market Cap
- $2.18K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.73
- Div Yield
- 0.00%
- Gross Margin
- 42.80%
- Op Margin
- -48.68%
- Net Margin
- -53.45%
- ROE
- 232.06%
- ROIC
- -235.46%
- Revenue
- $14.23M · -14.20%
- Net Income
- $-7,608,000 · -77.26%
- EPS
- $-0.36 · -71.43%
- Op Income
- $-6,930,000
- FCF YoY
- 22.87%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -80.29
- Avg Volume
- 1.28K
Get TickerSpark's AI analysis on ULGX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 19, 14 | EMERY SIDNEY W JR | sell | 10,000 |
| Nov 20, 14 | EMERY SIDNEY W JR | sell | 10,000 |
| Nov 6, 14 | EMERY SIDNEY W JR | other | 45,455 |
| Nov 7, 13 | EMERY SIDNEY W JR | other | 50,000 |
| Nov 16, 12 | EMERY SIDNEY W JR | other | 26,516 |
| Nov 16, 12 | EMERY SIDNEY W JR | other | 10,000 |
| Jun 29, 12 | EMERY SIDNEY W JR | buy | 20,000 |
| Dec 6, 11 | EMERY SIDNEY W JR | buy | 5,000 |
| Dec 2, 11 | EMERY SIDNEY W JR | buy | 100 |
| Dec 2, 11 | EMERY SIDNEY W JR | buy | 4,900 |
Our ULGX coverage
Recent articles, reports, and earnings notes.
No research on ULGX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ULGX report →Similar companies
Peers in the same neighborhood.